Obinutuzumab for Relapsing Myeloperoxidase-Antineutrophil Cytoplasmic Autoantibody–Associated Glomerulonephritis

Obinutuzumab for Relapsing Myeloperoxidase-Antineutrophil Cytoplasmic Autoantibody–Associated Glomerulonephritis

Saved in:

Bibliographic Details
Main Authors:	Michael Cammarata, Brendan Denvir, Aditi Singh, Bangchen Wang, Brendan Antiochos, Duvuru Geetha
Format:	Article
Language:	English
Published:	Elsevier 2025-06-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024925002517
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Explainability of a Deep Learning-Based Classification Model for Antineutrophil Cytoplasmic Autoantibody–Associated Glomerulonephritis
by: Maria A.C. Wester Trejo, et al.
Published: (2025-02-01)

Leukocyte Chemotactic Factor 2 Amyloidosis with Proteinase 3-Antineutrophil Cytoplasmic Antibody Positivity Manifesting as Rapidly Progressive Glomerulonephritis
by: Jaydeep Raj Damor, et al.
Published: (2025-04-01)

Pediatric Inflammatory Bowel Disease with Cytoplasmic Staining of Antineutrophil Cytoplasmic Antibodies
by: Omar I. Saadah, et al.
Published: (2013-01-01)

Antineutrophilic Cytoplasmic Antibody Positive Vasculitis Associated with Methimazole Use
by: Deep Shikha, et al.
Published: (2015-01-01)

On the problem of differential diagnosis in the detection of antineutrophil cytoplasmic antibodies
by: O. N. Egorova, et al.
Published: (2024-04-01)

Clinical perspective on serum periostin in antineutrophil-cytoplasmic antibody-associated vasculitis
by: Taejun Yoon, et al.
Published: (2025-05-01)

Damage to the organ of hearing and upper respiratory tract in vasculitis associated with antineutrophil cytoplasmic antibodies
by: A. A. Klimenko, et al.
Published: (2024-08-01)

Clinical features and outcomes of patients with antineutrophil cytoplasmic antibody-positive systemic lupus erythematosus
by: Ying Wang, et al.
Published: (2023-12-01)

Investigating potential biomarkers associated with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis using Mendelian randomization and transcriptomic analysis
by: Yujia Wang, et al.
Published: (2025-08-01)

Mass‐Forming Variants in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: Diagnostic Complexities in Granulomatous Disease. A Case Report
by: Benedetta Fazzi, et al.
Published: (2025-04-01)

ANCA-Associated Glomerulonephritis: Diagnosis and Therapy Proceedings of the Henry Shavelle Lectureship
by: Vanja Ivković, et al.
Published: (2024-12-01)

Avacopan in Anti-Neutrophil Cytoplasmic Autoantibodies–Associated Vasculitis in a Real-World Setting
by: Jonas Zimmermann, et al.
Published: (2024-09-01)

WCN24-756 POVETACICEPT, AN ENHANCED DUAL BAFF/APRIL ANTAGONIST, IN AUTOANTIBODY-ASSOCIATED GLOMERULONEPHRITIS
by: James Tumlin, et al.
Published: (2024-04-01)

A new formula consisting of the five-factor score and earliest vasculitis damage index at diagnosis for predicting poor outcomes of antineutrophil cytoplasmic antibody-associated vasculitis
by: Jang Woo Ha, et al.
Published: (2025-08-01)

Analyzing Antineutrophil Cytoplasmic Antibody Associated Conditions in a Large, Random Sample of Patients: A Comparison of Enzyme-Linked Immunosorbent Assay and Indirect Immunofluorescence Tests
by: Bedia Dinç, et al.
Published: (2025-08-01)

Early caplacizumab and obinutuzumab enable successful treatment of relapsing thrombotic thrombocytopenic purpura without therapeutic plasma exchange: a case report
by: Judith Schimpf, et al.
Published: (2025-04-01)

A diagnostic prediction model for anti-neutrophil cytoplasmic antibody associated vasculitis combined with glomerulonephritis based on machine learning algorithm
by: Wang Jian-mei, et al.
Published: (2025-02-01)

Autoantibodies Against Factor B and Factor H Without Pathogenic Effects in a Patient with Immune Complex-Mediated Membranoproliferative Glomerulonephritis
by: Alexandra T. Matola, et al.
Published: (2025-03-01)

Effectiveness and Safety of Polatuzumab Vedotin Plus an Anti‐CD20 Monoclonal Antibody (Rituximab or Obinutuzumab) and Zanubrutinib in Relapsed/Refractory Diffuse Large B‐Cell Lymphoma
by: Yian Zhang, et al.
Published: (2025-08-01)

Neutrophil-Mediated Regulation of Innate and Adaptive Immunity: The Role of Myeloperoxidase
by: Dragana Odobasic, et al.
Published: (2016-01-01)

Obinutuzumab as Initial or Second-Line Therapy in Patients With Primary Membranous Nephropathy
by: Xiaole Su, et al.
Published: (2024-08-01)

Obinutuzumab-induced severe acute thrombocytopenia: a case report and literature review
by: Kun Kou, et al.
Published: (2025-08-01)

Myeloperoxidase‐Antibody Positivity and Progression to Microscopic Polyangiitis in Interstitial Lung Disease: A Case Series
by: Michael Hoskins, et al.
Published: (2025-07-01)

Efficacy and safety of obinutuzumab in primary membranous nephropathy: a real-world retrospective study
by: Xi Cheng, et al.
Published: (2025-08-01)

Hydroxychloroquine reduces metastatic tumor burden in pancreatic adenocarcinoma through myeloperoxidase inhibition
by: Britney Niemann, et al.
Published: (2025-08-01)

WCN25-1022 LONG-TERM KIDNEY FUNCTION BEYOND 12 MONTHS AND KIDNEY RELAPSE AFTER INITIATION OF TREATMENT FOR ANCA-ASSOCIATED VASCULITIS
by: Lisa Uchida, et al.
Published: (2025-02-01)

Obinutuzumab and Ofatumumab are More Effective Than Rituximab in the Treatment of Membranous Nephropathy Patients With Anti-Rituximab Antibodies
by: Maxime Teisseyre, et al.
Published: (2025-03-01)

Perinuclear antineutrophilic cytoplasmatic antibodies at patients with ulcerative colitis and Crohn’s disease
by: Ye. A. Konovich, et al.
Published: (2009-10-01)

Obinutuzumab combined with bendamustine for the treatment of hairy cell leukemia variant: a case report and literature review
by: Junjun Bai, et al.
Published: (2025-08-01)

A LINK BETWEEN ACTIVE MYELOPEROXIDASE AND CHLORINATED CERULOPLASMIN IN BLOOD PLASMA OF PATIENTS WITH CARDIOVASCULAR DISEASES
by: A. V. Sokolov, et al.
Published: (2018-11-01)

Correlation between Myeloperoxidase and Interleukin-6 of Patients with Obstructive Sleep Apnea Syndrome in Thi-Qar Governorate
by: Mahdi Maid Yousif Albadri, et al.
Published: (2024-12-01)

Membranous glomerulonephritis and tuberculous peritonitis: a rare association
by: Biswadip Ghosh, et al.
Published: (2011-07-01)

Profile and Outcomes of Children with Acute Glomerulonephritis in Northwestern Nigeria
by: Olayinka Rasheed Ibrahım, et al.
Published: (2023-12-01)

The Causal Relationship between Plasma Myeloperoxidase Levels and Respiratory Tract Infections: A Bidirectional Mendelian Randomization Study
by: Xiu Liu, et al.
Published: (2024-01-01)

Determination of Serum Myeloperoxidase (MPO) and lactate dehydrogenase (LDH) as a tumour Marker in Chronic Myeloid Leukaemia (CML)
by: Khitam Abdul Wahhab Ali, et al.
Published: (2024-09-01)

Applications and challenges of glucocorticoids for anti-neutrophil cytoplasmic antibody-associated vasculitis
by: Wen Kai-lian, et al.
Published: (2022-12-01)

Complement in anti-glomerular basement membrane glomerulonephritis
by: Pei Zhang, et al.
Published: (2025-05-01)

WCN25-2572 C3 GLOMERULONEPHRITIS – A RARE CAUSE OF ACUTE GLOMERULONEPHRITIS IN A YOUNG MALE WITH HBH DISEASE
by: YASWANTH KILAPARTHI, et al.
Published: (2025-02-01)

Use of cytoplasmic male sterility in sorghum breeding for productivity
by: N. A. Kovtunova, et al.
Published: (2023-09-01)

Influenza a virus assembly intermediates fuse in the cytoplasm.
by: Seema S Lakdawala, et al.
Published: (2014-03-01)